Evidence map›Paper›PMID 38875708›Full record

ArticleACS biomaterials science & engineering2024

MgCa-Based Alloys Modified with Zn- and Ga-Doped CaP Coatings Lead to Controlled Degradation and Enhanced Bone Formation in a Sheep Cranium Defect Model.

Seyda Gokyer, Yanad Abou Monsef, Senem Buyuksungur, Jurgen Schmidt, Alina Vladescu Dragomir, Sencer Uygur, Cagdas Oto, Kaan Orhan, Vasif Hasirci, Nesrin Hasirci and 1 more

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seyda GokyerDepartment of Biomedical Engineering, Ankara University, Ankara 06830, Turkey.
Yanad Abou MonsefAnatomic Pathology Department, National Veterinary School of Toulouse, Toulouse 31300, France.
Senem BuyuksungurBIOMATEN, Center of Excellence in Biomaterials and Tissue Engineering, Middle East Technical University (METU), Ankara 06800, Turkey.
Jurgen SchmidtGruppenleiter Elektrochemie, Prüssingstraße 27b, INNOVENT e.V. Technologieentwicklung, Jena 07745, Germany.
Alina Vladescu Dragomir409 Atomistilor St., National Institute of R&D for Optoelectronics─INOE 2000, Magurele 77125, Romania.ORCID 0000-0001-5770-4541
Sencer Uygur
Cagdas Oto
Kaan Orhan
Vasif HasirciBIOMATEN, Center of Excellence in Biomaterials and Tissue Engineering, Middle East Technical University (METU), Ankara 06800, Turkey.
Nesrin HasirciBIOMATEN, Center of Excellence in Biomaterials and Tissue Engineering, Middle East Technical University (METU), Ankara 06800, Turkey.ORCID 0000-0002-4497-0194
Pinar YilgorDepartment of Biomedical Engineering, Ankara University, Ankara 06830, Turkey.ORCID 0000-0002-4912-0447

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mg-based biodegradable metallic implants are gaining increased attraction for applications in orthopedics and dentistry. However, their current applications are hampered by their high rate of corrosion, degradation, and rapid release of ions and gas bubbles into the physiological medium. The aim of the present study is to investigate the osteogenic and angiogenic potential of coated Mg-based implants in a sheep cranial defect model. Although their osteogenic potential was studied to some extent, their potential to regenerate vascularized bone formation was not studied in detail. We have studied the potential of magnesium-calcium (MgCa)-based alloys modified with zinc (Zn)- or gallium (Ga)-doped calcium phosphate (CaP) coatings as a strategy to control their degradation rate while enhancing bone regeneration capacity. MgCa and its implants with CaP coatings (MgCa/CaP) as undoped or as doped with Zn or Ga (MgCa/CaP + Zn and MgCa/CaP + Ga, respectively) were implanted in bone defects created in the sheep cranium. MgCa implants degraded faster than the others at 4 weeks postop and the weight loss was ca. 50%, while it was ca. 15% for MgCa/CaP and <10% in the presence of Zn and Ga with CaP coating. Scanning electron microscopy (SEM) analysis of the implant surfaces also revealed that the MgCa implants had the largest degree of structural breakdown of all the groups. Radiological evaluation revealed that surface modification with CaP to the MgCa implants induced better bone regeneration within the defects as well as the enhancement of bone-implant surface integration. Bone volume (%) within the defect was ca. 25% in the case of MgCa/CaP + Ga, while it was around 15% for undoped MgCa group upon micro-CT evaluation. This >1.5-fold increase in bone regeneration for MgCa/CaP + Ga implant was also observed in the histopathological examination of the H&E- and Masson's trichrome-stained sections. Immunohistochemical analysis of the bone regeneration (antiosteopontin) and neovascularization (anti-CD31) at the defect sites revealed >2-fold increase in the expression of the markers in both Ga- and Zn-doped, CaP-coated implants. Zn-doped implants further presented low inflammatory reaction, notable bone regeneration, and neovascularization among all the implant groups. These findings indicated that Ga- and Zn-doped CaP coating is an important strategy to control the degradation rate as well as to achieve enhanced bone regeneration capacity of the implants made of Mg-based alloys.

Indexed as

AlloysCalcium PhosphatesCoated Materials, BiocompatibleGalliumMagnesiumOsteogenesisSkullZincAbsorbable ImplantsAnimalsBone RegenerationCalciumSheepAlloysCalciumcalcium phosphateCalcium PhosphatesCoated Materials, BiocompatibleGalliumMagnesiumZincbiodegradable metalbone regenerationin vivoMg-based alloyneovascularizationsheep model

Identifiers

PMID38875708
PMCPMC11234335

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.